GENEVA, Aug. 31 -- LIANGZHU LABORATORY filed a patent application (CN2026/091169) for “CHEMOGENETIC GENE THERAPY METHOD FOR TREATING AUTISM SPECTRUM DISORDER DISEASE”. With publication no. WO/2026/175427, here are the other details related to the patent application:
Kind: Initial Publication without ISR [A2]
IPC: A61K 38/17
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....